We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 41-60 of 106 results
  1. Subependymal Giant Cell Astrocytoma: Role of mTOR Pathway and Its Inhibitors

    Subependymal giant cell astrocytoma is a distinct brain tumor growing near the foramen of Monro. Although histologically benign, these tumors may...
    Katarzyna Kotulska, Sergiusz Jóźwiak in Tumors of the Central Nervous System, Volume 5
    Chapter 2012
  2. Isolation and Characterization of Cancer Stem Cells from Dog Glioblastoma

    There is increasing evidence in some malignancies that the tumor clone is heterogeneous (phenotypically and functionally) in regard to proliferation...
    George Stoica, Gina Lungu in Stem Cells and Cancer Stem Cells, Volume 10
    Chapter 2013
  3. Subependymal Giant Cell Astrocytoma: Treatment

    Tuberous sclerosis complex (TSC), a ­relatively common genetic disorder, is associated with inactivation of tumor suppressor genes. Hence, tumors of...
    Chapter 2012
  4. Gangliogliomas and Other Low Grade Neuronal Neoplasms of the Central Nervous System: Diagnosis, Treatment, and Prognosis

    Glioneuronal tumors of the brain and spinal cord are relatively uncommon but highly interesting neoplasms, whose very existence provides support for...
    Douglas C. Miller, Wayne C. Paullus in Tumors of the Central Nervous System, Volume 9
    Chapter 2012
  5. Malignant Astrocytomas of the Spinal Cord: Clinicopathologic Parameters

    Malignant spinal cord astrocytomas are uncommon neoplasms that typically manifest with the acute onset of symptoms such as pain accompanied by motor...
    Mariarita Santi, Elisabeth J. Rushing in Tumors of the Central Nervous System, Volume 6
    Chapter 2012
  6. Epilepsy-Associated Brain Tumors: Diagnosis Using Magnetic Resonance Imaging

    In 20–30% of patients with long-term drug-resistant epilepsy neuroepithelial tumours are found. Glioneuronal tumours are much more frequent than...
    Chapter 2012
  7. Caveolin-1 in Brain Tumors

    Increasing evidences in the last years suggested a possible involvement of caveolin-1 (cav-1) in the biology of brain tumors. In vitro studies on...
    Chapter 2012
  8. Gangliogliomas: Molecular Pathogenesis and Epileptogenesis

    Gangliogliomas (GG) constitute the most frequent tumor entity in young patients undergoing surgery for intractable epilepsy. Surgery provides the...
    Eleonora Aronica, Pitt Niehusmann in Tumors of the Central Nervous System, Volume 5
    Chapter 2012
  9. Cancer Stem Cells and Glioblastoma Multiforme: Pathophysiological and Clinical Aspects

    Brain cancers although relatively rare, are responsible for disproportionately high morbidity and mortality due to the critical location of the...
    Akio Soeda, Mark E. Shaffrey, Deric M. Park in Advances in Cancer Stem Cell Biology
    Chapter 2012
  10. Immunohistochemistry in the Differential Diagnosis of Adult and Pediatric Brain Tumors

    Immunohistochemical stains are of increasing importance in evaluating adult and pediatric intracranial neoplasms. Surgical neuropathologists...
    Aditya Raghunathan in Pediatric Cancer, Volume 2
    Chapter 2012
  11. The Tumor Pathology of Genetically Engineered Mice: Genomic Pathology

    This chapter examines a newly emerging view of tumorigenesis by exploring the evidence that the molecular origin of the tumor determines the...
    Chapter 2012
  12. PROX1 is a predictor of survival for gliomas WHO grade II

    Background:

    The clinical course of World Health Organisation grade II gliomas remains variable and their time point of transformation into a more...

    T Elsir, M Qu, ... A Smits in British Journal of Cancer
    Article Open access 10 May 2011
  13. The Promoter Hypermethylation Status of GATA6, MGMT, and FHIT in Glioblastoma

    Glioblastoma (GBM) is an aggressive and lethal cancer, accounting for the majority of primary brain tumors in adults. GBMs are characterized by large...

    Gulsah Cecener, Berrin Tunca, ... Sahsine Tolunay in Cellular and Molecular Neurobiology
    Article 18 September 2011
  14. Demographic variation in incidence of adult glioma by subtype, United States, 1992-2007

    Background

    We hypothesized that race/ethnic group, sex, age, and/or calendar period variation in adult glioma incidence differs between the two broad...

    Robert Dubrow, Amy S Darefsky in BMC Cancer
    Article Open access 29 July 2011
  15. Iodine-125 brachytherapy for brain tumours - a review

    Iodine-125 brachytherapy has been applied to brain tumours since 1979. Even though the physical and biological characteristics make these implants...

    Silke B Schwarz, Niklas Thon, ... Friedrich-Wilhelm Kreth in Radiation Oncology
    Article Open access 06 March 2012
  16. Glioblastoma: Germline Mutation of TP53

    Various brain tumors are components of familial cancer syndromes, and Li-Fraumeni syndrome and Li-Fraumeni-like syndromes are the most famous...
    Haruhiko Sugimura, Hidetaka Yamada, ... Tomoaki Kahyo in Tumors of the Central Nervous System, Volume 2
    Chapter 2011
  17. Mechanisms of Immune Evasion by Gliomas

    A major contributing factor to glioma development and progression is its ability to evade the immune system. This chapter will explore the mechanisms...
    Cleo E. Rolle, Sadhak Sengupta, Maciej S. Lesniak in Glioma
    Chapter 2012
  18. Brain Tumors Arising in the Setting of Chronic Epilepsy

    Brain tumors, along with malformations of cortical development (cortical dysplasia), hippocampal sclerosis, and remote ischemic damage, are among the...
    Chapter 2011
  19. Genetic Signaling in Glioblastoma Multiforme (GBM): A Current Overview

    Cancers of the brain comprise a genetically and morphologically heterogeneous class of proliferating neural cells derived from incompletely...
    Walter J. Lukiw, Frank Culicchia in Neurochemical Mechanisms in Disease
    Chapter 2011
  20. Ex-vivo HRMAS of adult brain tumours: metabolite quantification and assignment of tumour biomarkers

    Background

    High-resolution magic angle spinning (HRMAS) NMR spectroscopy allows detailed metabolic analysis of whole biopsy samples for investigating...

    Alan J. Wright, Greg A. Fellows, ... Franklyn A. Howe in Molecular Cancer
    Article Open access 23 March 2010
Did you find what you were looking for? Share feedback.